Bianca Rocca
Bianca Rocca
Associate Professor of Pharmacology, Catholic University School of Medicine, Rome
Verified email at unicatt.it
Title
Cited by
Cited by
Year
Role of prostacyclin in the cardiovascular response to thromboxane A2
Y Cheng, SC Austin, B Rocca, BH Koller, TM Coffman, T Grosser, ...
Science 296 (5567), 539-541, 2002
9332002
Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 Years
GIS Policitemia
Annals of Internal Medicine 123, 656-664, 1995
4541995
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
B Rocca, P Secchiero, G Ciabattoni, FO Ranelletti, L Catani, L Guidotti, ...
Proceedings of the National Academy of Sciences 99 (11), 7634-7639, 2002
3812002
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of theá…
V Regitz-Zagrosek, JW Roos-Hesselink, J Bauersachs, ...
European heart journal 39 (34), 3165-3241, 2018
3752018
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ...
European heart journal, 2019
362*2019
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a singleá…
M Seri, A Pecci, F Di Bari, R Cusano, M Savino, E Panza, A Nigro, P Noris, ...
Medicine 82 (3), 203-215, 2003
3202003
Cyclooxygenases and prostaglandins: shaping up the immune response
B Rocca, GA FitzGerald
International immunopharmacology 2 (5), 603-630, 2002
2822002
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays Implications for Aspirin “Resistance”
F Santilli, B Rocca, R De Cristofaro, S Lattanzio, L Pietrangelo, A Habib, ...
Journal of the American College of Cardiology 53 (8), 667-677, 2009
2492009
Cardiovascular Responses to the Isoprostanes iPF-III and iPE2-III Are Mediated via the Thromboxane A2 Receptor In Vivo
LP Audoly, B Rocca, JE Fabre, BH Koller, D Thomas, AL Loeb, ...
Circulation 101 (24), 2833-2840, 2000
2102000
Cyclooxygenase-2 expression and inhibition in atherothrombosis
F Cipollone, B Rocca, C Patrono
Arteriosclerosis, thrombosis, and vascular biology 24 (2), 246-255, 2004
2032004
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes
B Rocca, F Santilli, D Pitocco, L Mucci, G Petrucci, E Vitacolonna, ...
Journal of Thrombosis and Haemostasis 10 (7), 1220-1230, 2012
1982012
Position of nonmuscle myosin heavy chain IIA (NMMHC‐IIA) mutations predicts the natural history of MYH9‐related disease
A Pecci, E Panza, N Pujol‐Moix, C Klersy, F Di Bari, V Bozzi, P Gresele, ...
Human mutation 29 (3), 409-417, 2008
1822008
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target
S Pascale, G Petrucci, A Dragani, A Habib, F Zaccardi, F Pagliaccia, ...
Blood, The Journal of the American Society of Hematology 119 (15), 3595-3603, 2012
1582012
Aspirin: promise and resistance in the new millennium
C Patrono, B Rocca
Arteriosclerosis, thrombosis, and vascular biology 28 (3), s25-s32, 2008
1542008
Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development
B Rocca, LM Spain, E PurÚ, R Langenbach, C Patrono, GA FitzGerald
Journal of Clinical Investigation 103 (10), 1469-1477, 1999
1541999
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
F Andreotti, B Rocca, S Husted, RA Ajjan, J ten Berg, M Cattaneo, ...
European Heart Journal 36 (46), 3238-3249, 2015
1522015
Drug insight: aspirin resistance—fact or fashion?
C Patrono, B Rocca
Nature clinical practice Cardiovascular medicine 4 (1), 42-50, 2007
1422007
Determinants of the interindividual variability in response to antiplatelet drugs
B Rocca, C Patrono
Journal of Thrombosis and Haemostasis 3 (8), 1597-1602, 2005
1142005
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment
R Landolfi, B Rocca, C Patrono
Critical reviews in oncology/hematology 20 (3), 203-222, 1995
1101995
Prognostic significance of cyclooxygenase‐2 in laryngeal squamous cell carcinoma
FO Ranelletti, G Almadori, B Rocca, G Ferrandina, G Ciabattoni, A Habib, ...
International journal of cancer 95 (6), 343-349, 2001
1082001
The system can't perform the operation now. Try again later.
Articles 1–20